Wang Katherine M, Sirich Tammy L, Chang Tara I
Department of Medicine, Stanford Division of Nephrology, Palo Alto, California.
Department of Medicine, VA Palo Alto Healthcare System, Palo Alto, California.
Semin Dial. 2019 May;32(3):201-204. doi: 10.1111/sdi.12777. Epub 2019 Mar 5.
Intradialytic hypotension (IDH) is a prevalent yet serious complication of hemodialysis, associated with decreased quality of life, inadequate dialysis, vascular access thrombosis, global hypoperfusion, and increased cardiovascular and all-cause mortality. Current guidelines recommend antihypertensive medications be given at night and held the morning of dialysis for affected patients. Despite little evidence to support this recommendation, more than half of patients on dialysis may employ some form of this method. In this article, we will review the available evidence and clinical considerations regarding timing of blood pressure medications and occurrence of IDH, and conclude that witholding BP medications before hemodialysis should not be a routine practice.
透析中低血压(IDH)是血液透析常见且严重的并发症,与生活质量下降、透析不充分、血管通路血栓形成、全身灌注不足以及心血管和全因死亡率增加有关。当前指南建议,对于受影响的患者,应在夜间给予抗高血压药物,并在透析当天早晨停用。尽管几乎没有证据支持这一建议,但超过一半的透析患者可能会采用某种形式的这种方法。在本文中,我们将回顾关于血压药物给药时间与IDH发生情况的现有证据及临床考量,并得出结论:血液透析前停用降压药物不应成为常规做法。